EnerSpar Corp. (TSE:NRX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NurExone Biologic Inc. has announced promising data for ExoPTEN, its nanodrug that demonstrates precise targeting of inflammation and injury sites, which is a crucial step towards commercial manufacturing. The study validated the use of NurExone’s exosomes for drug delivery and the quality of siRNA from its new GMP-compliant manufacturing partner. These advancements bring the company closer to clinical trials and potential commercialization of their non-invasive therapies for Central Nervous System injuries.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.
